The human immune response is generated and regulated by a complex set of cellular interactions between subsets of T cells, B cells and antigen-presenting macrophages. The molecules which govern these interactions are surface membrane glycoproteins which become expressed during differentiation. Many of these molecules define unique subsets of cells and are also intimately involved in the function of the cells they define. During the last several years, our laboratory has been particularly concerned with the CD4 and CD8 molecules which are simultaneously expressed on the majority of thymocytes, but during terminal differentiation become expressed on the surface of the mutually exclusive subsets of T cells. Mounting evidence suggests that these molecules have dual functions. First, they are thought to be receptor structures for conserved regions of MHC molecules (CD4 recognizing class II and CD8 recognizing class I MHC). Second, they are involved in transmitting regulatory signals to T cells during antigen activation. In order to more precisely define the immunobiology of these molecules, we have isolated and sequenced the genes and cDNA's encoding these molecules. A major thrust of this renewal proposal will be to continue to employ recombinant DNA technology to create mutant CD4 and CD8 molecules and, following gene transfer to relevant cells and clones, define the structure function relationships of these molecules. In addition, we will extend these studies to other known functionally interesting differentiation antigens on immunocompetent cells, including CD5 which is expressed on T cells and a subset of B cells. Finally, we will employ the monoclonal antibody and gene isolation technologies which have been used successful to date in the analysis of DC 4 and CD8 in order to define new cell surface molecules important in the control of human T cell functions. Because T cells are known to be intimately involved in the immunopathology of most immunologic diseases of man, including AIDS, we believe our studies will contribute basic data that my be essential to further understanding of these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI014969-12
Application #
3125946
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1978-04-01
Project End
1994-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
12
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Lederman, S; Cleary, A M; Yellin, M J et al. (1996) The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes. Curr Opin Hematol 3:77-86
Cleary, A M; Fortune, S M; Yellin, M J et al. (1995) Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol 155:3329-37
Ware, R; Jiang, H; Braunstein, N et al. (1995) Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells. Immunity 2:177-84
Jiang, H; Ware, R; Stall, A et al. (1995) Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity 2:185-94
Covey, L R; Cleary, A M; Yellin, M J et al. (1994) Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Mol Immunol 31:471-84
Yellin, M J; Sinning, J; Covey, L R et al. (1994) T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 153:666-74
Lederman, S; Yellin, M J; Cleary, A M et al. (1994) T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152:2163-71
Yellin, M J; Sippel, K; Inghirami, G et al. (1994) CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 152:598-608
Lederman, S; Yellin, M J; Covey, L R et al. (1993) Non-antigen signals for B-cell growth and differentiation to antibody secretion. Curr Opin Immunol 5:439-44
Lederman, S; Yellin, M J; Inghirami, G et al. (1992) Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149:3817-26

Showing the most recent 10 out of 20 publications